NCT06777940 Effects of Kegel Exercises and Myokinetic Release of Trigger Points in Primary Dysmenorrhea
| NCT ID | NCT06777940 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Primary Dysmenorrhea |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-12-23 |
| Primary Completion | 2025-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-12-23 with a primary completion date of 2025-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The rationale of this study is despite the widespread belief that exercise can reduce dysmenorrhea, evidence-based studies are limited. Studies are therefore required to evaluate the association between quality of life and the primary dysmenorrheal females, the functional impact on the quality of life and primary dysmenorrhea females also it's a crucial time for females to focus on their studies and dysmenorrhea can add to the fatigue levels and cause distress in this age group thus the purpose of this study is to determine whether myokinetic active release of trigger points in the rectus abdominis, gluteus medius and quadratus lumborum is a more effective way to reduce dysmenorrhea than kegel exercises
Eligibility Criteria
Inclusion Criteria: * Age 17-25 years * Diagnosed cases of dysmenorrhea * Subject having trigger point in rectus abdominins, quadratus lumborum and gluteus medius * With regular cycles 21-35 days lasting 3-7 days Exclusion Criteria: * Oral contraceptives used for menstrual irregularity * Other gynecological disease like fibroids, endometriosis * Who take analgesia * Endometrial polyp, having pelvic infection using IUD, having venous congestion in internal genital organs.
Contact & Investigator
Iqra abdul ghafoor, PPDPT
PRINCIPAL INVESTIGATOR
riphah international univrsity
Frequently Asked Questions
Who can join the NCT06777940 clinical trial?
This trial is open to female participants only, aged 17 Years or older, up to 25 Years, studying Primary Dysmenorrhea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06777940 currently recruiting?
Yes, NCT06777940 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06777940 trial being conducted?
This trial is being conducted at Lahore, Pakistan, Lahore, Pakistan.
Who is sponsoring the NCT06777940 clinical trial?
NCT06777940 is sponsored by Riphah International University. The principal investigator is Iqra abdul ghafoor, PPDPT at riphah international univrsity. The trial plans to enroll 50 participants.